Anti-Cancer Drugs Market to Reach US$ 576.48 Billion by 2034, Growing at 10.61% CAGR
The Cancer remains one of the leading causes of mortality worldwide, driving pharmaceutical companies and healthcare providers to focus on the development of highly effective anti-cancer drugs. Technological advancements in drug discovery, increased adoption of precision medicine, and favorable regulatory support are accelerating the commercialization of next-generation oncology therapies. Furthermore, the increasing awareness regarding early … Read more